News

The verification system in Latvia to prevent falsified medicines reaching patients has been fully operational for two years – a total of 22 million packages of medicines in Latvia have been checked by the system and delivered to the patients within 2020

The Latvian Medicines Verification Organization (LZVO) has supplemented its registered client portal with a new module, which is intended for system end users in Latvia

On 13 January 2021, the European Commission adopted a new Delegated Regulation, amending Delegated Regulation (EU) 2016/161 as regards a derogation from the obligation of wholesalers to decommission the unique identifier of products exported to the United Kingdom.

The Latvian medicines verification system, which was established in Latvia to check the safety of medicines and prevent people from receiving or buying falsified medicines, has been fully operational for almost two years.

As the Emergency Situation in Latvija is extended until 7 February, Latvian Medicines Verification Organization (LZVO) will work in a mixed mode, both remotely and on-site.

A new board member Evita Jaunzeme, who is representing manufacturers of innovative medicinal products (Association of International Innovative Pharmaceuticals Producers) and manufacturers of generic medicinal products (Latvian Generic Medicines Association), has been appointed on the board of Latvian Medicines Verification Organisation (LZVO) since December 8, 2020. E. Jaunzeme is Gedeon Richter Plc. Head of the Representation in Latvia.